Suppr超能文献

[急性支气管炎中抗生素治疗的合理应用]

[Rational use of antibiotics treatment in acute bronchitis].

作者信息

Dellamonica P

机构信息

Maladies Infectieuses et Tropicales, Hôpital de l'Archet, BP 689, F-06012 Nice, France.

出版信息

Med Mal Infect. 1992 Feb;22:149-152. doi: 10.1016/S0399-077X(05)81464-7. Epub 2005 Jun 20.

Abstract

Acute bronchitis in healthy patient in mainly related to virus. Intra-cellular bacteria, are rarely involved. For these reasons, macrolides or cyclines (except for children) are justified in first line treatment. For patients with acute exacerbation of chronic bronchitis, the choice of the treatment needs to be discuss. At the initial stage, most of the pathogens involved are those of acute bronchitis. Antibiotic is only prescribes for the prevention of a superinfection; this kind of prophylaxis has to be evaluated. Few days after, histological due to modifications of bronchi, a superinfection can occur which needs a curative treatment. In most of the data reported the literature, there is no distinction between the two periods of the disease. It is interesting to point out that associated treatments such as kinesitherapy, corticosteroids can modify the natural course of bronchitis. There are not evaluated as associated treatment in the different clinical trials.

摘要

健康患者的急性支气管炎主要与病毒有关。细胞内细菌很少涉及。出于这些原因,大环内酯类或四环素类(儿童除外)作为一线治疗是合理的。对于慢性支气管炎急性加重的患者,治疗方案的选择需要讨论。在初始阶段,涉及的大多数病原体与急性支气管炎相同。抗生素仅用于预防二重感染;这种预防措施必须进行评估。几天后,由于支气管的组织学改变,可能会发生二重感染,这需要进行根治性治疗。在文献报道的大多数数据中,并未区分疾病的这两个阶段。值得指出的是,诸如运动疗法、皮质类固醇等辅助治疗可以改变支气管炎的自然病程。在不同的临床试验中,它们并未作为辅助治疗进行评估。

相似文献

1
[Rational use of antibiotics treatment in acute bronchitis].
Med Mal Infect. 1992 Feb;22:149-152. doi: 10.1016/S0399-077X(05)81464-7. Epub 2005 Jun 20.
2
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.
3
Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines.
Chest. 2006 Jan;129(1 Suppl):95S-103S. doi: 10.1378/chest.129.1_suppl.95S.
5
Antibiotics in the treatment of acute exacerbations of chronic bronchitis.
Expert Opin Investig Drugs. 2002 Jul;11(7):911-25. doi: 10.1517/13543784.11.7.911.
9
Prophylactic antibiotic therapy for chronic bronchitis.
Cochrane Database Syst Rev. 2003(1):CD004105. doi: 10.1002/14651858.CD004105.

本文引用的文献

1
Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro.
Am Rev Respir Dis. 1982 Sep;126(3):449-51. doi: 10.1164/arrd.1982.126.3.449.
2
Human pulmonary macrophage-derived mucus secretagogue.
J Exp Med. 1984 Mar 1;159(3):844-60. doi: 10.1084/jem.159.3.844.
3
Human monocyte-derived mucus secretagogue.
J Clin Invest. 1985 Jan;75(1):191-8. doi: 10.1172/JCI111674.
4
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
Ann Intern Med. 1987 Feb;106(2):196-204. doi: 10.7326/0003-4819-106-2-196.
5
Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis.
J Infect Dis. 1987 May;155(5):985-90. doi: 10.1093/infdis/155.5.985.
6
Clinical and physiological manifestations of bronchiolitis and pneumonia. Outcome of respiratory syncytial virus.
Am J Dis Child. 1979 Aug;133(8):798-802. doi: 10.1001/archpedi.1979.02130080038006.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验